Option Care Health (NASDAQ:OPCH - Get Free Report) was downgraded by research analysts at Truist Financial from a "strong-buy" rating to a "hold" rating in a report issued on Wednesday, Zacks reports.
A number of other research analysts have also weighed in on the stock. Citizens Jmp reissued a "market perform" rating on shares of Option Care Health in a report on Wednesday. Stephens reiterated an "equal weight" rating and set a $24.00 price objective (down from $30.00) on shares of Option Care Health in a research report on Friday, July 17th. UBS Group reissued a "buy" rating on shares of Option Care Health in a research note on Tuesday, September 22nd. Zacks Research upgraded shares of Option Care Health from a "strong sell" rating to a "hold" rating in a report on Monday, July 6th. Finally, Wall Street Zen upgraded shares of Option Care Health from a "hold" rating to a "buy" rating in a research report on Saturday, August 1st. Three equities research analysts have rated the stock with a Buy rating and thirteen have assigned a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of "Hold" and an average target price of $29.70.
Read Our Latest Stock Report on Option Care Health
Option Care Health Price Performance
Shares of Option Care Health stock opened at $31.01 on Wednesday. The stock has a 50 day moving average of $23.92 and a 200 day moving average of $23.57. Option Care Health has a 12 month low of $18.01 and a 12 month high of $36.80. The firm has a market cap of $4.64 billion, a PE ratio of 23.32, a PEG ratio of 1.79 and a beta of 0.58. The company has a current ratio of 1.47, a quick ratio of 0.98 and a debt-to-equity ratio of 0.91.
Option Care Health (NASDAQ:OPCH - Get Free Report) last released its quarterly earnings data on Wednesday, July 29th. The company reported $0.45 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.43 by $0.02. The business had revenue of $1.44 billion for the quarter, compared to the consensus estimate of $1.42 billion. Option Care Health had a return on equity of 18.74% and a net margin of 3.68%.The company's revenue was up 1.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.41 EPS. Option Care Health has set its FY 2026 guidance at 1.850-1.920 EPS. On average, research analysts expect that Option Care Health will post 1.7 EPS for the current fiscal year.
Institutional Inflows and Outflows
A number of hedge funds have recently bought and sold shares of OPCH. Andina Capital Management LLC lifted its position in Option Care Health by 2.6% during the fourth quarter. Andina Capital Management LLC now owns 16,320 shares of the company's stock worth $520,000 after buying an additional 419 shares in the last quarter. Pacer Advisors Inc. grew its holdings in Option Care Health by 1.3% in the 1st quarter. Pacer Advisors Inc. now owns 42,649 shares of the company's stock valued at $1,148,000 after buying an additional 528 shares in the last quarter. Central Pacific Bank Trust Division increased its stake in shares of Option Care Health by 3.9% in the 3rd quarter. Central Pacific Bank Trust Division now owns 14,369 shares of the company's stock worth $323,000 after acquiring an additional 540 shares during the last quarter. State of Michigan Retirement System increased its stake in shares of Option Care Health by 1.6% in the 1st quarter. State of Michigan Retirement System now owns 38,159 shares of the company's stock worth $1,027,000 after acquiring an additional 600 shares during the last quarter. Finally, Oregon Public Employees Retirement Fund raised its holdings in shares of Option Care Health by 2.5% during the 1st quarter. Oregon Public Employees Retirement Fund now owns 32,530 shares of the company's stock worth $876,000 after acquiring an additional 800 shares during the period. Institutional investors own 98.05% of the company's stock.
Trending Headlines about Option Care Health
Here are the key news stories impacting Option Care Health this week:
- Positive Sentiment: The definitive acquisition agreement provides a clear cash valuation and near-term potential for shareholders, while the stock’s trading below the $32.05 offer price leaves a merger-arbitrage spread if the transaction closes as planned. CD&R and McKesson Corporation Sign Agreement to Acquire Option Care Health
- Positive Sentiment: Unusually heavy call-option activity and trading volume indicate significant speculative interest following the takeover announcement, although these signals do not guarantee additional gains. Option Care Health Rockets as CD&R and McKesson Table 37% Premium Bid
- Neutral Sentiment: JPMorgan reaffirmed a Neutral rating with a $33 price target, while Citizens JMP and Barrington Research maintained Market Perform ratings. The targets suggest limited upside beyond the announced offer and reflect the likelihood that the deal, rather than operating performance, will determine the stock’s value.
- Neutral Sentiment: Investors are booking gains and focusing on deal completion rather than standalone fundamentals. Zacks noted that recent earnings-estimate trends may not support further upside independent of the acquisition. Strength Seen in Option Care
- Negative Sentiment: Several shareholder-rights law firms are investigating whether the $32.05 offer fairly values Option Care Health and whether insiders received benefits unavailable to public shareholders. Such reviews could increase deal-related uncertainty or encourage demands for a higher bid. Ademi LLP OPCH Shareholder Alert
Option Care Health Company Profile
(
Get Free Report)
Option Care Health, Inc NASDAQ: OPCH is a provider of home and alternate-site infusion services in the United States. The company works with patients, physicians, hospitals, health plans and pharmaceutical manufacturers to deliver and manage infusion therapy outside traditional hospital settings, including in patients' homes, ambulatory infusion suites and other community-based locations.
Its services include the provision and administration of specialty medications and other infusion therapies for conditions such as infections, immune disorders, chronic diseases and nutritional deficiencies.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.